Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

12.10
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
2.73
Today|||52-Week Range
12.96
+129.17%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close12.10
Today’s open12.06
Day’s range11.70 - 12.35
Volume26,600
Average volume (3 months)33,292
Market cap$257.4M
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)-21.31%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.56

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...0.000.00%
STDYSteadymed Ltd0.000.00%
BLRXBioLine RX Ltd0.000.00%
GLMDGalmed Pharmaceutica...0.000.00%
Data as of 1:00pm ET, 11/24/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts